This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser.
Print Document
View Excel Document
Cover
Document And Entity Information
Financial Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statements Of Income
Consolidated Statements Of Stockholders' Equity And Comprehensive Income
Consolidated Statements Of Cash Flows
Notes to Financial Statements
Organization And Summary Of Significant Accounting Policies
Marketable Investment Securities
Fair Value Measurements
Goodwill And Other Intangible Assets
Leases
Share-Based Compensation
Stockholders' Equity
Income Taxes
Employee Deferred Savings Plan
Segment And Related Information
Stockholder Rights Plan
Investment In Prolexys Pharmaceuticals, Inc.
Commitments And Contingencies
Acquisitions
Spin-Off Of Myriad Pharmaceuticals, Inc.
Valuation And Qualifying Accounts
Accounting Policies
Organization And Summary Of Significant Accounting Policies (Policy)
Notes Tables
Organization And Summary Of Significant Accounting Policies (Tables)
Marketable Investment Securities (Tables)
Fair Value Measurements (Tables)
Goodwill And Other Intangible Assets (Tables)
Leases (Tables)
Share-Based Compensation (Tables)
Stockholders' Equity (Tables)
Income Taxes (Tables)
Employee Deferred Savings Plan (Tables)
Segment And Related Information (Tables)
Acquisitions (Tables)
Spin-Off Of Myriad Pharmaceuticals, Inc. (Tables)
Valuation And Qualifying Accounts (Tables)
Notes Details
Organization And Summary Of Significant Accounting Policies (Narrative) (Details)
Organization And Summary Of Significant Accounting Policies (Summary Of Other-Than-Temporary Impairments Recognized) (Details)
Organization And Summary Of Significant Accounting Policies (Schedule Of Depreciation Expense) (Details)
Organization And Summary Of Significant Accounting Policies (Reconciliation Of Denominators Of Basic And Diluted Earnings Per Share) (Details)
Organization And Summary Of Significant Accounting Policies (Schedule Of Anti-Dilutive Options Excluded From EPS Computation) (Details)
Marketable Investment Securities (Schedule Of Fair Value For Available-For-Sale Securities By Major Security Type And Class Of Security) (Details)
Marketable Investment Securities (Schedule Of Maturities Of Debt Securities Classified As Cash Equivalents And Available-For-Sale) (Details)
Marketable Investment Securities (Schedule Of Debt Securities Available-For-Sale In A Gross Unrealized Loss Position) (Details)
Fair Value Measurements (Schedule Of Fair Value Of Financial Assets) (Details)
Goodwill And Other Intangible Assets (Details)
Goodwill And Other Intangible Assets (Schedule Of Future Estimated Amortization Expense) (Details)
Leases (Narrative) (Details)
Leases (Summary Of Rental Expense) (Details)
Leases (Future Minimum Lease Payments) (Details)
Leases (Summary Of Lease Payments Received) (Details)
Leases (Expected Future Minimum Lease Payments Receivable) (Details)
Share-Based Compensation (Narrative) (Details)
Share-Based Compensation (Schedule Of Fair Value Of Stock Option Grant With Weighted-Average Assumptions) (Details)
Share-Based Compensation (Schedule Of Share-Based Compensation Arrangement By Share Based Payment Award Options Outstanding) (Details)
Share-Based Compensation (Schedule Of Share-Based Compensation Arrangement By Share Based Payment Award Options Outstanding And Options Exercisable) (Details)
Share-Based Compensation (Schedule Of Share-Based Compensation Recognized In Statements Of Operations) (Details)
Share-Based Compensation (Schedule Of Unrecognized Share-Based Compensation Cost) (Details)
Share-Based Compensation (Schedule Of Intrinsic Value Of Options Exercised) (Details)
Share-Based Compensation (Schedule Of Shares Purchased And Compensation Expenses) (Details)
Stockholders' Equity (Narrative) (Details)
Stockholders' Equity (Schedule Of Components Of Comprehensive Income) (Details)
Stockholders' Equity (Schedule Of Stock Repurchases) (Details)
Income Taxes (Narrative) (Details)
Income Taxes (Schedule Of Income Tax Expense (Benefit) (Details)
Income Taxes (Schedule Of Differences Between Statutory Federal Income Tax Rate And Income Taxes Reported In Consolidated Statements Of Operations) (Details)
Income Taxes (Schedule Of Components Of Deferred Tax Assets And Liabilities) (Details)
Income Taxes (Schedule Of Net Changes In Valuation Allowance) (Details)
Income Taxes (Schedule Of Reconciliation Of Beginning And Ending Unrecognized Tax Benefits) (Details)
Employee Deferred Savings Plan (Details)
Segment And Related Information (Schedule Of Segment Performance Based On Income (Loss) From Continuing Operations Before Interest Income And Other Income And Expense) (Details)
Segment And Related Information (Schedule Of Total Operating Income For Continuing Reportable Segments) (Details)
Segment And Related Information (Schedule Of Comparison Of Balance Sheet Assets By Operating Segment) (Details)
Segment And Related Information (Reconciliation Of Assets By Operating Segment To Total Assets) (Details)
Stockholder Rights Plan (Details)
Investment In Prolexys Pharmaceuticals, Inc. (Details)
Acquisitions (Details)
Spin-Off Of Myriad Pharmaceuticals, Inc. (Narrative) (Details)
Spin-Off Of Myriad Pharmaceuticals, Inc. (Schedule Of Net Book Value Of The Net Assets Transferred To MPI In Connection With The Spin-Off) (Details)
Spin-Off Of Myriad Pharmaceuticals, Inc. (Schedule Of Significant Components Of Research And Drug Development Operations) (Details)
Valuation And Qualifying Accounts (Details)
All Reports
Rendering Log